Table 1 Comparison of diagnostic test sensitivity
Serum sample | Comparison of diagnostic test sensitivity (95% CI) [n/N] | |||||
|---|---|---|---|---|---|---|
Source | EIE®LVC | DPP® LVC | DPP rLci1A | DPP rLci2B | DPP rLci1A/rLci2B | DPP® LVC + DPPrLci1A/rLci2B |
BA | 98% | 92.5% | 66% | 81.1% | 83% | 96.2% |
(86–100) | (82–97) | (53–77) | (69–89) | (71–91) | (87–99) | |
[49/50] | [49/53] | [35/53] | [43/53] | [44/53] | [51/53] | |
MG | 93.5% | 84% | 70% | 76% | 84% | 88% |
(92–100) | (72–92) | (56–81) | (63–86) | (72–92) | (76–94) | |
[43/46] | [42/50] | [35/50] | [38/50] | [42/50] | [44/50] | |
RN | 100% | 88.2% | 90.2% | 90.2% | 94.1% | 96% |
(93–100) | (77–95) | (79–96) | (79–96) | (84–98) | (87–99) | |
[51/51] | [45/51] | [46/51] | [46/51] | [48/51] | [49/51] | |
Total* | 97.3% | 88.3% | 75.3% | 82.5% | 87% | 93.5% |
(93–99) | (82–93) | (68–82) | (76–88) | (81–91) | (89–96) | |
[143/147**] | [136/154] | [116/154] | [127/154] | [134/154] | [144/154] | |